Cic9201, Hegp, Aphp,
Paris, 75015, France
NCT Number: NCT01935752
Fibromuscular dysplasia is an non inflammatory non atherosclerotic obstructive arterial disease affecting mid-size arteries. It is considered as a rare vascular disease of unknown origin. Fibromuscular dysplasia may become symptomatic depending on location and severity of narrowing of the arterial lumen. for example,when a stenosis develops within a renal artery, arterial hypertension may develop. The cause of fibromuscular dysplasia is unknown. Several factors have been suggested to be associated with it: tobacco abuse or oestrogens. In order to progress into identifying possible causative mechanisms of the disease, we design a pathophysiology study destined to assess endothelial function in patients with fibromuscular dysplasia and to identify possible plasmatic biomarkers of the disease.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Paris, 75015, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for patients with multifocal fibromuscular dysplasia:
blood samples
endothelial function study and virtual histology study
Time frame: Once within 15 days
Time frame: Once within 15 days
Time frame: Once within 15 days
Time frame: Once within 15 days
Time frame: Once within 15 days
Time frame: Once within 15 days
Time frame: Once within 15 days
Time frame: Once within 15 days
Assistance Publique - Hôpitaux de Paris
Other
Acronym: MeDyA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02961868
Arterial Occlusive Diseases, Brain Diseases
Brussels, Brussels Capital, Belgium
View Trial DetailsNCT02884141
Arterial Occlusive Diseases, Brain Diseases
Brussels, Brussels Capital, Belgium
View Trial DetailsNCT02528149
Arterial Occlusive Diseases, Cardiovascular Diseases
Aurillac, France
View Trial DetailsNCT01808729
Arterial Occlusive Diseases, Arteriosclerosis
New York, United States
View Trial Details